By combining advanced technology with a human element, Antidote is able to filter out ineligible participants and provide a great patient experience.

These advancements underscore Antidote and MRA’s unwavering commitment to improving the clinical trial search experience for those impacted by melanoma.

In the competitive healthtech sector, user acquisition can be a challenge — but Antidote can help our app partners in the healthcare space reach patients.

Vanessa Chase Lockshin, President of The Storytelling Nonprofit, discussed how to start nonprofit blogs and measure their success for an organization.

Antidote’s founder was interviewed for the Relentless Health Value podcast to discuss clinical trial recruitment and retention and where we go from here.

For World Lupus Day on May 10, we talked with lupus blogger and advocate MarlaJan Wexler about living with the disease.

This World Mental Health Day, we had a Q&A session with NAMI to discuss mental health day activities, clinical trials, and more.

In honor of World Cancer Day, we're sharing some of the most exciting oncology research breakthroughs.

When used effectively, ePRO in clinical trials have the potential to improve both data quality and the patient experience.

Getting a drug to market is an expensive process, but there are smart ways to reduce clinical trial patient recruitment costs.

When enrolling patients in a clinical trial, recruitment is just part of the equation — which is why Antidote offers support for trial sites, too.

Because there is often no cure for kidney disease, medical research that reflects the patient population is important to discovering new treatments.